0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Research Letter | 
William Toppen, BA; Sohail Sareh, MS; Daniel Johansen, BA; et al.
JAMA Surg. 2016;151(4):389-391. doi:10.1001/jamasurg.2015.4212.

Invited Commentary | 
Claudio Baracchini, MD; Enzo Ballotta, MD
JAMA Surg. 2016;151(3):255-256. doi:10.1001/jamasurg.2015.3615.

Original Investigation |  ONLINE FIRST
Yi Li, MD, PhD; Luca Stocchi, MD; Deepa Cherla, MD; et al.
JAMA Surg. Published online February 24, 2016. doi:10.1001/jamasurg.2015.5558

Original Investigation | 
Mark L. Friedell, MD; Charles W. Van Way III, MD; Ron W. Freyberg, MS; et al.
JAMA Surg. 2015;150(7):658-663. doi:10.1001/jamasurg.2015.86.
Includes: CME

Original Investigation |  FREE
Eileen M. Bulger, MD; Ronald V. Maier, MD; Jason Sperry, MD; et al.
JAMA Surg. 2014;149(6):528-536. doi:10.1001/jamasurg.2013.4841.
Includes: CME, Supplemental Content

Invited Critique | 
Martin A. Makary, MD, MPH
Arch Surg. 2007;142(3):284. doi:10.1001/archsurg.142.3.284.

Original Article |  FREE
Amy L. Friedman, MD; Sarah R. Geoghegan, BSN; Noelle M. Sowers, RN; et al.
Arch Surg. 2007;142(3):278-283. doi:10.1001/archsurg.142.3.278.
Includes: CME

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA
News From the Food and Drug Administration  | 
Olanzapine Linked With Potentially Fatal Skin Reaction
Rebecca Voelker, MSJ
JAMA Psychiatry
Original Investigation  | 
Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression A Randomized Clinical Trial
Jorge A. Quiroz, MD, MBA; Paul Tamburri, PharmD; Dennis Deptula, PhD; et al.